Mashukur Rahman/LinkedIn
Feb 8, 2026, 14:09
Mashukur Rahman: New ESC Dyslipidemia Updates Expand the Role of Statins
Mashukur Rahman, Resident Doctor at Bangladesh Medical University, Medical Officer at Directorate General of Health Services, shared a post on LinkedIn.
“Many doctors still think statins are only for high LDL cholesterol.
But the new ESC dyslipidemia updates suggest a bigger role.
Why this matters now:
- Statins may help protect the heart in some cancer patients.
Some chemotherapy drugs like anthracyclines can cause heart failure years later. Preventive statin use is getting stronger support. - We are moving from treating numbers to treating overall risk.
Risk builds silently, even when LDL is not very high.
In real life, we often wait for LDL to cross a ‘clear cutoff.’
But by then, damage may already be starting.
If statins are becoming broader heart-protection drugs — when should we start them in borderline-risk patients?”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation
-
Nov 8, 2026, 05:34Eugene Bolotin: Thrombosis and Survival in Pancreatic Cancer
-
Nov 8, 2026, 05:24Recognising Bleeding Disorders in Adolescents With Heavy Menstrual Bleeding – RPTH Journal
-
Nov 8, 2026, 05:11WFH CCS 2027 Abstract Submission Now Open – World Federation of Hemophilia